<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T08:39:41Z</responseDate><request verb="GetRecord" identifier="oai:dspace.mit.edu:1721.1/58400" metadataPrefix="dim">https://dspace.mit.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:dspace.mit.edu:1721.1/58400</identifier><datestamp>2022-01-13T07:53:45Z</datestamp><setSpec>com_1721.1_7582</setSpec><setSpec>com_1721.1_7581</setSpec><setSpec>col_1721.1_131023</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Fiona E. Murray and Chris Varma.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Chang, Joanne</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="other" lang="en_US">Harvard University--MIT Division of Health Sciences and Technology.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Harvard University--MIT Division of Health Sciences and Technology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2010-09-03T18:36:02Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2010-09-03T18:36:02Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="copyright" lang="en_US">2010</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2010</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/1721.1/58400</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="oclc" lang="en_US">656253175</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010.</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">Cataloged from PDF version of thesis.</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">Includes bibliographical references (p. 69-71).</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more "venture-oriented" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">S.M.</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="extent" lang="en_US">71 p.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">eng</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Massachusetts Institute of Technology</dim:field>
   <dim:field mdschema="dc" element="rights" lang="en_US">M.I.T. theses are protected by 
copyright. They may be viewed from this source for any purpose, but 
reproduction or distribution in any format is prohibited without written 
permission. See provided URL for inquiries about permission.</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri" lang="en_US">http://dspace.mit.edu/handle/1721.1/7582</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Harvard University--MIT Division of Health Sciences and Technology.</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang.</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="others" element="access-status">unknown</dim:field>
   <dim:field mdschema="others" element="access-status">unknown</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="ee20babe-891b-4f7b-bbf1-e51e6edfd6ef">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>eng&lt;/Language>
   	&lt;Title>Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang.&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2010&lt;/PublicationDate>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Chang, Joanne&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;DisplayName>Massachusetts Institute of Technology&lt;/DisplayName>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;License>http://dspace.mit.edu/handle/1721.1/7582&lt;/License>
    &lt;Keyword>Harvard University--MIT Division of Health Sciences and Technology.&lt;/Keyword>
   	&lt;Abstract>The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more &amp;quot;venture-oriented&amp;quot; model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>